Half of Americans suffer from some degree of insufficient sleep, from missing a few occasional hours, to debilitating insomnia and other sleep disorders. It’s little wonder many cannabis consumers, both medical and recreational, cite insomnia or other conditions that can lead to loss of sleep, like anxiety or stress, as primary reasons for their cannabis use.
The UNM study looked at sales data for OTC medication in select Colorado counties and found a correlation between demand for sleep aids and cannabis access, measuring UPC-level data and number of dispensaries among other metrics. Drug store staples diphenhydramine — the active ingredient in Benadryl, and doxylamine, sold under the brand name Unisom — were most affected. These drugs are primarily antihistamines that can cause drowsiness with low levels of efficacy in treating sleeplessness.
The study did not conclude that cannabis is more effective in treating disturbances, however, merely that consumers preferred marijuana over traditional OTC alternatives. Researchers further urged that investigations into both the efficacy and the side-effects of cannabis compared to OTC treatments is needed right away, so as to better treat sleeplessness while minimizing any potential harmful side effects.
TheGrowthOp 71,0000 Canadians just lost their jobs and 48% of Canadians are within 200.00 of not being able to pay their monthly bills while Trudeau keeps piling the carbon taxes on raising the cost of groceries...maybe politicians should deal with Canada’s DIRE ECONOMIC OUTLOOK.....